EK - PZ18 - 02 HC (Male) in Raipur

EK - PZ18 - 02 HC (Male) test includes three tests; glycosylated hemoglobin test, glucose-fasting blood test, and PSA total. The glycosylated hemoglobin test measures the percentage of glycosylated hemoglobin in the blood, while a glucose-fasting blood test measures the glucose level during fasting. Glucose is the main form of sugar utilized by the body to release energy; it is absorbed by the intestine and distributed to all organs through blood. These tests help your doctor to monitor your blood sugar levels and manage your diabetes well. The PSA total test identifies conditions affecting prostate health. Getting tested with the EK - PZ18 - 02 HC (Male) package enables you to make lifestyle modifications and adopt healthier food choices to improve your overall health. 

Note:

• Tumor Markers are specialized tests and values should only be interpreted by experts (clinicians) in the concerned field.
• This test should not be used alone for the diagnosis of cancer as both false positives and false negatives can occur. A negative value does not rule out the possibility of cancer. 
• Tumor marker measurements are not recommended for patients with vague symptoms or screening in the general population esp. when the population likelihood of cancer is low.
• Tumor markers help in the detection of tumors in high-risk cases and monitor the course of disease and response to therapy/ surgery.
• Tumor markers also lack specificity for a particular cancer, and there are numerous non-malignant (benign) conditions in which they may be increased - resulting in false positive tests. 
• Regardless of value, the tumor marker test should not be interpreted as absolute evidence for the presence or absence of malignant disease. The test value should be used in conjunction with clinical history, clinical examination, and other diagnostic procedures to reach a final diagnosis. 
• Testing should be avoided in conditions where tumor markers give variable and inaccurate results, e.g. CA125 in women during menstruation and pregnancy, and PSA in men with active urinary tract infections. 
• Some procedures may transiently raise levels, e.g. CEA levels after colonoscopy, PSA after digital rectal examination (DRE) or rectal prostatic ultrasonography, CA125 after abdominal surgery. It is advisable to consult your doctor regarding the appropriate timing of the test after such procedures. 

PSA test:

• The prostate-specific antigen (PSA) blood test is used, often along with a digital rectal exam, for prostate cancer screening in men 50 years and older, but a prostatic biopsy is required for the diagnosis of cancer. 
• For men in high-risk groups, or men with a first-degree relative diagnosed at a younger age, testing should begin at a younger age. 
• PSA is used in the management of previously diagnosed prostate cancer, for detecting tumor recurrence, and as an indicator of response to therapy. 
• Elevated concentrations of PSA may be observed in the serum of patients with benign prostatic hyperplasia or other non-malignant disorders like prostatitis as well as in prostate cancer. Furthermore, low PSA concentrations do not rule out cancer. 
• PSA test should not be done immediately after cystoscopy, digital rectal examination, ejaculation, prostatic massage, indwelling catheterization, ultrasonography and needle biopsy of the prostate as they falsely elevate levels.